Histone
methyltransferase SMYD2, SET and MYND domain-containing protein 2,
Smyd2, Lysine N-methyltransferase 3C, MGC119305, N lysine
methyltransferase SMYD2
Immunogen
Recombinant protein corresponding to Mouse SMYD2
Isotype
IgG
Purity
Affinity purification
Subcellular location
Nucleus, Cytoplasm
Uniprot ID
Q8R5A0, Q7M6Z3
Applications
Applications
Species
Dilution
Positive Sample
IHC/IF
Mouse, Rat
1: 1000-1: 4000
Bone fibroids, brain, heart, Skeletal muscle
Background
Protein-lysine
N-methyltransferase that methylates both histones and non-histone
proteins. Specifically methylates histone H3 'Lys-4' (H3K4me) and
dimethylates histone H3 'Lys-36' (H3K36me2). Has also methyltransferase
activity toward non-histone proteins such as p53/TP53 and RB1.
Monomethylates 'Lys-370' of p53/TP53, leading to decreased DNA-binding
activity and subsequent transcriptional regulation activity of p53/TP53.
Images
Immunohistochemistry of paraffin embedded mouse heart using SMYD2 (GB111583) at dilution of 1:2000 (400x lens)
Immunofluorescence of paraffin embedded mouse brain using SMYD2 (GB111583) at dilution of 1:2000 (400x lens)
Immunofluorescence of paraffin embedded mouse Skeletal muscle using SMYD2 (GB111583) at dilution of 1:1000 (400x lens)
Immunofluorescence of paraffin embedded rat Bone fibroids using SMYD2 (GB111583) at dilution of 1:2000 (400x lens)
Immunofluorescence of paraffin embedded rat heart using SMYD2 (GB111583) at dilution of 1:2000 (400x lens)
Storage
Storage
Store at -20 ℃ for one year. Avoid repeated freeze/thaw cycles.
Storage Buffer
PBS with 0.02%sodium azide,100 μg/ml BSA and 50% glycerol.
Storage
Store at -20 ℃ for one year. Avoid repeated freeze/thaw cycles.
Storage Buffer
PBS with 0.02%sodium azide,100 μg/ml BSA and 50% glycerol.
Storage
Store at -20 ℃ for one year. Avoid repeated freeze/thaw cycles.
Storage Buffer
PBS with 0.02%sodium azide,100 μg/ml BSA and 50% glycerol.
NOTE:
1.This product is intended for research only.
2.This product is recommended to dilute with the Primary Antibody Dilution Buffer (G2025).